Skip to content

Pulmonary and Ventilatory Effects of Trigger Modulation in Intubated ICU

Pulmonary and Ventilatory Effects of Trigger Modulation in Intubated ICU Patients Spontaneously Breathing With Pressure Support Ventilation. A Physiopathology Exploratory Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04041817
Acronym
Trigger
Enrollment
30
Registered
2019-08-01
Start date
2019-04-03
Completion date
2023-01-31
Last updated
2023-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICU Patients, Intubation, Pulmonary Function, Spontaneously Breathing, Tracheotomy

Keywords

ICU, Pressure support ventilation, Spontaneous breathing, Trigger, Weaning of mechanical ventilation

Brief summary

Pressure support ventilation allows intubated ICU patients to breathe spontaneously. Among specific settings, the adjustment of the trigger value (or threshold for triggering the ventilator) has not been explored to date. The trigger threshold corresponds to the sensitivity of the ventilator to detect patient's inspiratory effort and then deliver the predefined pressure support to inflate the lungs and deliver a tidal volume. The purpose of this study is to explore the influence of trigger level on pulmonary and ventilatory physio (-patho)logical parameters in spontaneously breathing ICU patients.

Detailed description

The use of invasive mechanical ventilation is one of the most frequent therapies in intensive care units (ICUs). There are several types of indications, depending on the failure: essentially neurological, hemodynamic or respiratory. In recent years, the notion of lung damage induced by mechanical ventilation (VILI) has led to major changes in ventilator settings in both ICUs and operative rooms (Ors). The reduction of the tidal volume (TV) to 6-8 mL/kg of ideal body weight, the use of an individualized positive end-of-expiratory pressure (PEEP) and the possible use of pulmonary aeration optimization therapies (alveolar recruitment manoeuvres, prone positioning sessions...) have become essential to increase patient's survival. Withdrawal of invasive mechanical ventilation remains a daily issue and traditionally requires the transition from fully controlled ventilation to pressure support ventilation. Among specific settings of the latter, the adjustment of the trigger value (or threshold for triggering the ventilator) has not been explored to date. The trigger threshold corresponds to the sensitivity of the ventilator to detect patient's inspiratory effort and then deliver the predefined pressure support to inflate the lungs and deliver a tidal volume. The lower (or more sensitive) the trigger threshold, the smallest patient's effort will be rewarded. On the other hand, the higher the threshold, the greater the inspiratory effort required from the patient. Usually, this value is set by default to the minimum level to avoid self-triggering of the ventilator. With the objective to optimize pulmonary aeration, the use of higher trigger levels could increase diaphragmatic work (with a potential re-training and reinforcement effect) and contribute to better alveolar recruitment in the postero-inferior territories that are traditionally the most impacted, following a higher diaphragmatic motion. The authors propose to explore the impact of different trigger levels on pulmonary aeration (evaluated by electrical impedance tomography) and ventilatory parameters, in order to validate our hypotheses and before considering a trial with the objective of defining individualized trigger levels, according to patient's respiratory mechanics and pulmonary parenchyma morphology, with potential benefits on ventilator weaning.

Interventions

OTHERTrigger setting of pressure support ventilation

Trigger variations will be performed following increasing steps of 3 L/min every 15 minutes, from 0.2 to 15 L/min (0.2 - 3 - 6 - 9 - 12 - 15).

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

Statistical analysis will be conducted by an independant statistician not involved in data collection

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * Patient hospitalized in the Intensive Care Unit of Clermont-Ferrand's Hospital * Patients with mechanical invasive ventilation in spontaneous ventilation with inspiratory support (intubation or tracheostomy) * Trigger level set to minimum * Patient under sedation compatible with spontaneous ventilation (SV) with inspiratory support (AI) and positive end-expiratory pressure (PEP) Patient calm (RASS between -2 and 0) Consent for participation or consent from patient's next of kin or inclusion according to an emergency procedure Patient benefiting from the French social security scheme

Exclusion criteria

* Refusal to participate in the proposed study * Contraindication to the installation of a nasogastric tube: * Severe disorder of uncorrected blood clotting * Known nasosinus lesion * Oesophageal varices recently ligated (\<48h) * Contraindication to the use of the electro-impedancemetry technique by tomography * Thoracic lesions * Chest dressings * Pace-maker / Implantable Defibrillator * Known lesion of central respiratory centers, including patients with neurological injury * Patients with Acute Respiratory Distress Syndrome (according to Berlin criteria) * Patients with restrictive or obstructive pulmonary pathology * Patients admitted post-operatively for surgery that may affect the diaphragmatic function ( thoracic or abdominal supra-mesocolic) * Patients with abdominal distention (ileus, intra-abdominal hyperpressure) * Patient whose BMI is greater than 35 kg.m-2 * Pregnant patient * Patient under guardianship,

Design outcomes

Primary

MeasureTime frameDescription
Lung volume (end expiratory lung volume, EELV) at each trigger levelT0 (before the first trigger step)The main endpoint is the difference between the lung volume (EELV) measured by electroimpedancemetry by tomography (EIT) at the end of each trigger level (15th minute) and the basal value measured at the beginning of the protocol

Secondary

MeasureTime frameDescription
Regional impedance variationThrough study completion, 150 minutesEvaluation of regional impedance variation (TIV: Tidal Impedance Variation) by EIT
AtelectraumaThrough study completion, 150 minutesAssessement of atelectrauma (RVD: Regional Ventilation Delay) by EIT
Lung volume variationsThrough study completion, 150 minutesEvaluation of lung volume variations by EIT (EELI : End Expiratory Lung Impedance)
Transpulmonary pressureThrough study completion, 150 minutesEvaluation of maximum transpulmonary pressure (alveolar stress)
Alveolar strain defined as the ratio between tidal volume and Functional Residual CapacityThrough study completion, 150 minutesAlveolar strain defined as the ratio between tidal volume and Functional Residual Capacity
Homogeneity of pulmonary aerationThrough study completion, 150 minutesEvaluation of homogeneity of pulmonary aeration with Center Of Ventilation by EIT
Work of breathingThrough study completion, 150 minutesEvaluation of work of breathing (WOB) value (P01)
Energy deliveredMeasurement during the last minute of each trigger stepEvaluation of energy delivered to lungs patient
Diaphragm thickeningThrough study completion, 150 minutesEvaluation of the diaphragmatic thickening by ultrasound
Diaphragm motionThrough study completion, 150 minutesEvaluation of the diaphragmatic motion by ultrasound
Patient's weightThrough study completion, 150 minutesStudy of the impact of patient's weight
Transpulmonary driving pressureThrough study completion, 150 minutesEvaluation of transpulmonary driving pressure

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026